Renske Hebing

20182020

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory Diseases

van Lint, J. A., Jessurun, N. T., Hebing, R. C. F., Hoentjen, F., Tas, S. W., Vonkeman, H. E., van Doorn, M. B. A., Sobels, A., Spuls, P. I., van Puijenbroek, E. P., Nurmohamed, M. T. & van den Bemt, B. J. F., 1 Jan 2020, (Accepted/In press) In : Drug Safety.

Research output: Contribution to journalArticleAcademicpeer-review

Patients with inflammatory rheumatic diseases: quality of self-reported medical information in a prospective cohort event monitoring system

Kosse, L. J., Jessurun, N. T., Hebing, R. C. F., Huiskes, V. J. B., Spijkers, K. M., van den Bemt, B. J. F. & Nurmohamed, M. T., 1 Jun 2020, In : Rheumatology (Oxford, England). 59, 6, p. 1253-1261 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Efficacious transition from reference infliximab to biosimilar infliximab in clinical practice

Layegh, Z., Ruwaard, J., Hebing, R. C. F., l’ Ami, M. J., van der Weele, W., Nurmohamed, M. T., Krieckaert, C. & Wolbink, G., 1 May 2019, In : International Journal of Rheumatic Diseases. 22, 5, p. 869-873

Research output: Contribution to journalArticleAcademicpeer-review

Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence

van Heuckelum, M., Linn, A. J., Vandeberg, L., Hebing, R. C. F., van Dijk, L., Vervloet, M., Flendrie, M., Nurmohamed, M. T., van Dulmen, S., van den Bemt, B. J. F. & van den Ende, C. H. M., 2019, In : PLoS ONE. 14, 8, e0221290.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access